The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 02, 2025
Filed:
Oct. 22, 2021
The Broad Institute, Inc., Cambridge, MA (US);
Biogen MA Inc., Cambridge, MA (US);
Florence Fevrier Wagner, Cambridge, MA (US);
Michel Weiwer, Cambridge, MA (US);
Arthur J. Campbell, Cambridge, MA (US);
Joshua R. Sacher, Cambridge, MA (US);
Edward Holson, Newton Highlands, MA (US);
Brian Stuart Lucas, Arlington, MA (US);
Teyu Chen, Cambridge, MA (US);
The Broad Institute, Inc., Cambridge, MA (US);
Biogen MA Inc., Cambridge, MA (US);
Abstract
The present disclosure provides compounds of Formula (I), and salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof. The provided compounds may be useful for inhibiting kinases, e.g., glycogen synthase kinase 3 (GSK3). The provided compounds may be able to selectively inhibit GSK3a, as compared to GSK3P and/or other kinases. The present disclosure further provides pharmaceutical compositions, kits, and methods of use, each of which involve the compounds. The compounds, pharmaceutical compositions, and kits may be useful for treating diseases associated with aberrant activity of GSK3a (e.g., Fragile X syndrome, attention deficit hyperactivity disorder (ADHD), childhood seizure, intellectual disability, diabetes, acute myeloid leukemia (AML), autism, and psychiatric disorder).